GlassScriptPhysician profile
Ira M Weinstein
NPI 1023097680
$23,420.04
in general payments reported to CMS, 2019-2025
48 companies · $4,321 in 2025
The $4,321 reported for 2025 was more than what 92% of Critical Care Medicine (Internal Medicine) providers received nationally (typical 2025 total: $189).
See the full distribution for Critical Care Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,467 · 2020: $2,054 · 2021: $2,916 · 2022: $3,531 · 2023: $3,468 · 2024: $4,663 · 2025: $4,321.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $12K · Education: $197.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $12,254.19 |
| Education | $197.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $3,177.12 | 2019-2025 | Fasenra, Breztri, Airsupra |
| Glaxosmithkline, LLC. | $2,875.53 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $2,196.48 | 2019-2025 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Harmony Biosciences LLC | $1,891.04 | 2020-2025 | Wakix |
| Genzyme Corporation | $1,330.50 | 2019-2025 | |
| Insmed, INC. | $1,274.77 | 2019-2025 | Arikayce, Brinsupri |
| Jazz Pharmaceuticals INC. | $1,209.93 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $1,059.67 | 2019-2025 | Dupixent |
| Grifols USA, LLC | $990.95 | 2019-2025 | Prolastin-C Liquid |
| Takeda Pharmaceuticals U.S.A., INC. | $699.68 | 2020-2025 | Glassia |
| Genentech USA, INC. | $695.89 | 2019-2025 | Xolair |
| Mylan Specialty L.P. | $611.63 | 2019-2024 | Yupelri |
| Novartis Pharmaceuticals Corporation | $483.09 | 2019-2024 | |
| Axsome Therapeutics, INC. | $475.39 | 2023-2025 | Sunosi |
| Philips North America LLC | $382.30 | 2019-2023 |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $376.46 | 2021-2025 | Tezspire |
| Baxter Healthcare | $332.36 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System, Hillrom - Volara System |
| Actelion Pharmaceuticals US, INC. | $315.70 | 2019-2025 | Opsumit, Uptravi, Opsynvi |
| Electromed, INC. | $312.09 | 2019-2025 | Smartvest |
| United Therapeutics Corporation | $297.64 | 2021-2025 | Tyvaso, Tyvaso |
| Vifor Pharma, INC. | $267.28 | 2024-2025 | Zemaira |
| Avadel Cns Pharmaceuticals, LLC | $236.07 | 2023-2025 | Lumryz |
| Noctrix Health, INC. | $222.55 | 2025 | Nidra |
| Verona Pharma, INC. | $206.38 | 2025 | Ohtuvayre |
| Viatris Specialty LLC | $167.42 | 2025 | Yupelri |
| Inspire Medical Systems, INC. | $151.19 | 2023-2025 | Inspire |
| Paratek Pharmaceuticals, INC. | $125.61 | 2019-2022 | |
| Resmed Corp | $122.50 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $121.67 | 2019-2021 | |
| Inogen, INC. | $91.20 | 2020-2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Pfizer INC. | $90.01 | 2019-2025 | |
| Mallinckrodt Hospital Products INC. | $89.96 | 2020-2022 | |
| Sunovion Pharmaceuticals INC. | $88.29 | 2019-2020 | |
| Shire North American Group INC | $79.98 | 2019 | |
| Sanofi-Aventis U.S. LLC | $74.75 | 2023 | |
| Teva Pharmaceuticals USA, INC. | $66.76 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $41.92 | 2019-2023 | Keytruda |
| Circassia INC. | $27.79 | 2019 | |
| Zoll Respicardia, INC. | $23.27 | 2023 | Remede System |
| Gilead Sciences, INC. | $20.88 | 2021 | |
| Fisher & Paykel Healthcare INC | $18.28 | 2019 | |
| Tactile Systems Technology INC | $17.02 | 2022 | |
| Allergan, INC. | $16.31 | 2019 | |
| Itamar Medical INC | $16.20 | 2021 | |
| Mallinckrodt Enterprises LLC | $13.97 | 2019 | |
| Horizon Therapeutics Plc | $13.66 | 2019 | |
| Advanced Respiratory, INC | $10.99 | 2019 | |
| Biomerieux INC | $9.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ira Weinstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.